Department of Dermatology, Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
NCT Number: NCT05722444
This study will evaluate subjective sleep over three consecutive menstrual cycles (menses and non-menses) in females reporting heavy menstrual bleeding. Following a baseline phase of one menstrual cycle, study subjects will use a standardized nighttime feminine product during menstruation for their second cycle. For the third cycle, subjects will continue to use the standardized menstrual product with behavioral modification that includes refraining from those sleep behaviors used to avoid nighttime menstrual leakage.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During nights while menstruating:
Time frame: 3 months
Determine the change in PSQI over the 3 months of study participation. Maximum score is 21 (worse sleep outcomes) and minimum score is 0 (better sleep outcomes).
Northwestern University
Other
Investigation of Sleep and Health Outcomes in Women Reporting Heavy Menses Flow
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07701525
46, XX Disorders of Sex Development, Adnexal Diseases
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07680985
Adenomyosis, Dysmenorrhea
Wenzhou, Zhejiang, China
View Trial DetailsNCT07518693
Abnormal Uterine Bleeding, Adenomyosis
Bengbu, Anhui, China
View Trial DetailsNCT03670680
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bron, France
View Trial Details